Current Investigations

Change Healthcare Cyberattack Investigation

Girard Sharp is investigating reports of a cyberattack that may have affected critical medical and administrative services for Change Healthcare customers. Service issues reportedly include: substantial billing and cash flow disruptions, limited electronic remittance advice from health plans, rejections of prior authorization submissions, prescription delays and practices being unable to perform patient eligibility checks

New York Community Bancorp Inc. (NYCB) Securities Investigation

Girard Sharp LLP is investigating potential claims on behalf of New York Community Bancorp (NYCB) stockholders who have sustained recent losses due to recent reports regarding the company’s business operations and prospects.

CooperSurgical Embryo Loss Legal Investigation

Girard Sharp attorneys are investigating reports surrounding CooperSurgical, Inc.’s recall of its embryo culture solution—which is used for in vitro fertilization. The defective solution reportedly was used in in vitro fertilization (IVF) procedures around the country and reportedly was discovered to have killed the developing embryos of its customers. test

Results

Maxar Technologies, Inc.
$36,500,000

Girard Sharp served as co-lead counsel in a certified securities class action on behalf of investors of Maxar Technologies, Ltd. (NYSE: MAXR) regarding alleged violations of federal securities laws for material misstatements and omissions associated with the performance and economic outlook of one of its core business units. The court granted preliminary approval of a $36.5 million settlement in June 2023.

MacBook Keyboard Litigation
$50,000,000

Girard Sharp served as co-lead counsel in the certified product defect class action against Apple on behalf of purchasers of MacBook laptops equipped with Apple’s allegedly defective butterfly keyboard. The court granted final approval of a $50 million settlement in May 2023.

Pacific Fertility Center
$14,000,000

Girard Sharp represents IVF patients of Pacific Fertility Center whose eggs and embryos were damaged or destroyed in a cryopreservation tank failure. On June 11, 2021, after a three-week trial, a jury found the tank manufacturer, Chart Industries Inc., liable for a defect in the tank and for its negligent failure to recall a part that malfunctioned, a “controller” meant to monitor liquid nitrogen levels. The jury awarded more than $14 million in damages to three women who lost eggs and a married couple who lost embryos in the catastrophic March 2018 tank failure. The three women were each awarded between $2 million and $3 million, and the couple was awarded $7.2 million. Girard Sharp represents over 80 families who lost reproductive material in the tank failure.

Pending Cases

Google Digital Advertising Antitrust Litigation, Southern District of New York

Girard Sharp serves as interim co-lead counsel in the Google Digital Advertising Antitrust Litigation, a multidistrict litigation pending in the United States District Court for the Southern District of New York. Girard Sharp filed the first digital advertising monopoly class action against Google, several months before the U.S. Department of Justice and a group of state attorneys general sued Google for monopolization.

In re. Subaru Battery Drain Products Liability Litigation

Co-lead counsel in class action alleging defective electronic system resulting in premature battery failures in Subaru vehicles.

Shirin Bayati & Mojan Kamalvand v. GWG Holdings

Representing purchasers of GWG Holdings, Inc. in a class action lawsuit alleging that the company may have made false and misleading statements to investors in connection with the issuance and sale of L Bonds.